🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 163 of 200 · A–Z by INN

  1. sacubitril + valsartan

    ENTRESTO Novartis Pharmaceuticals

    TGA: approved

  2. safflower oil

    LIPOSYN 10%

    INJECTION FDA: approved

  3. safinamide

    ARX-SAFINAMIDE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    N04B

  4. safinamide mesylate

    SAFINAMIDE MESYLATE

    ORAL FDA: approved

  5. salicylic acid

    NULL

    TGA: approved

  6. salicylic acid (extemporaneous formula)

    NULL

    TGA: approved

  7. salicylic acid + lactic acid

    DUOFILM SOLUTION GlaxoSmithKline

    TGA: approved

  8. salicylic acid and sulfur aqueous

    NULL

    TGA: approved

  9. salicylic acid ointment

    NULL

    TGA: approved

  10. saline

    NMPA: clinical trials

  11. salmeterol

    SEFFALAIR SPIROMAX Teva Pharma GmbH

    EMA: approved

    R03AK06

  12. salmeterol product

    SEREVENT ACCUHALER GlaxoSmithKline

    TGA: approved

  13. salmeterol xinafoate

    AIREXAR SPIROMAX Teva Pharma GmbH

    INHALATION FDA: approved · EMA: withdrawn

    R03AK06

  14. samarium [153sm] lexidronam pentasodium

    QUADRAMET

    EMA: approved

    V10BX02

  15. samarium sm-153 lexidronam pentasodium

    QUADRAMET

    INJECTION FDA: approved

  16. samrotecan

    NMPA: clinical trials

  17. sanguisorba

    NMPA: clinical trials

  18. sapropterin

    KUVAN BioMarin Pharmaceutical Australia Pty Ltd

    EMA: approved · TGA: approved

    A16AX07

  19. sapropterin dihydrochloride

    SAPROPTERIN DIHYDROCHLORIDE BioMarin Pharmaceutical Australia Pty Ltd

    ORAL FDA: approved

  20. saquinavir

    FORTOVASE

    ORAL FDA: approved · EMA: withdrawn

    J05AE01

  21. saquinavir mesylate

    INVIRASE

    ORAL FDA: approved

  22. sar443122

    NMPA: clinical trials

  23. saralasin acetate

    SARENIN

    INJECTION FDA: approved

  24. sarcosine

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources